Delivery Order SPE2DB20D3104-SPE2DB24FV9M2

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,563,239,341 units of Desmopressin 40 mcg/10 ml vial (10 ml) to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $5,679.62 Firm Fixed Price contract was awarded on January 4, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of January 5, 2024. This appears to be a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,784.61 Firm Fixed Price Delivery Order is for the supply of 4,560,025,678 units of Desmopressin Acetate 0.1 mg tablets. The contract has a completion date of February 23, 2023 and was awarded on February 22, 2023 with no set-aside designation. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,432.70 firm fixed-price delivery order is funded by the DLA, an agency under the Department of Defense. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,501.62 firm fixed-price delivery order is for 20 DRAM 1-CLIC AMBER VIALS, with a completion date of December 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,032.40 firm fixed-price delivery order is for AMPHADASE 150 UNITS/ML VIAL, a medical product. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,547.04 firm fixed-price delivery order is for the procurement of 4,567,887,721 pre-filled ampules (0.25 mL). The contract has an ultimate completion date of April 14, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
The U.S. government awarded a $1,714.17 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to supply a range of pharmaceutical products and medical supplies. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,626.62 firm fixed-price delivery order is for 36,000 units of a pharmaceutical product, with an ultimate completion date of February 14, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,947.27 firm-fixed-price delivery order contract has an ultimate completion date of December 30, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,354.80 Firm Fixed Price delivery order contract has an ultimate completion date of January 6, 2025. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV9M2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,105.80 firm fixed-price delivery order contract is for the supply of desmopressin acetate 4 mcg/mL ampules. This contract is a task order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables efficient government procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular award did not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of September 13, 2024.

Generated 2/27/25, 12:11 PM